Ampath Chats

COVID-19 Antibody Testing

Ampath Chats
COVID-19 Antibody Testing
Read Document

PATHCHAT Edition No. 68
August 2020
Please contact your local Ampath pathologist for more information.

Authors:

  • Dr. Cathy van Rooyen (Immunologist)
  • Dr. Marieke Brauer (Clinical Virologist)

Introduction

What is SARS-CoV-2 Antibody Testing?

  • Determines whether a patient has previously been exposed to SARS-CoV-2, the virus causing COVID-19.
  • Not used for diagnosing active infection.
  • Helpful in epidemiological research and assessing immune response.

📌 PCR remains the gold standard for diagnosing active COVID-19 infections.

Symptoms of COVID-19

Common Symptoms:

  • Fever.
  • Cough.
  • Difficulty breathing.
  • Flu-like symptoms.

Incubation Period:

  • 2 to 14 days (median of ~5 days).

📌 Some individuals may have mild or no symptoms while still being infected.

Antibody Response to SARS-CoV-2

Stages of Immune Response:

  • Incubation Period: No circulating antibodies.
  • Acute Infection:
    • IgM antibodies appear first.
    • IgG follows a few days later.
  • Seroconversion (Day 14–16 after symptom onset):
    • IgM and/or IgG detectable in ~90% of infected individuals.

📌 Antibody development varies between individuals and may wane over time.

Indications for SARS-CoV-2 Antibody Testing

Recommended Uses:

  1. Epidemiological Research & Community Surveillance:
    • Healthcare settings.
    • Care homes.
    • Workplaces.
  2. Outbreak Investigation & Prevention.
  3. Limited Clinical Use (≥14 Days After Symptoms Onset):
    • Diagnosing past infection when PCR was negative or not performed.
    • Assessing suspected COVID-19 in children with multisystem inflammatory syndrome (PIMS).

📌 Antibody tests should not be used for diagnosing active infection.

Who Should NOT Be Tested?

Patients With Suspected Active COVID-19 Infection

  • PCR is the appropriate diagnostic test for current infection.

📌 Serology cannot confirm active infection and should not replace PCR testing.

Specimen Collection for SARS-CoV-2 Antibody Testing

Sample Requirements:

  • Single blood sample (clotted tube – red or yellow top).
  • No special handling required.
  • Specimens can be collected at any routine Ampath lab or depot (except those within hospital facilities).

📌 Proper sample collection ensures accurate antibody testing results.

Interpretation of SARS-CoV-2 Antibody Test Results

Negative Antibody Test:

  • IgG antibodies to SARS-CoV-2 not detected.
  • Possible explanations:
    • Test performed too soon after infection (<14 days).
    • Patient had mild/asymptomatic infection and did not develop detectable antibodies.
    • Antibodies have waned (some evidence suggests they decline after ~3 months).

Positive Antibody Test:

  • Indicates likely past SARS-CoV-2 infection.
  • Does NOT confirm protective immunity or duration of immunity.
  • Active infection should still be ruled out using PCR if clinically indicated.

📌 The presence of IgG antibodies does not guarantee long-term immunity against reinfection.

Key Considerations for COVID-19 Antibody Testing

Limitations & Considerations:

  • Antibody tests are most reliable when performed ≥14 days after symptom onset.
  • False positives are rare but possible due to cross-reactivity with other coronaviruses.
  • False negatives may occur if testing is done too early or in patients with weak immune responses.
  • Clinical history and PCR testing should guide interpretation of results.

📌 Antibody testing should be used alongside other clinical and epidemiological data.

Contact Information

For Assistance with Interpretation:

  • Local pathologists or Ampath Immunology Department (National Reference Laboratory).
  • Contact: 012 678 0614/3.

📌 Laboratory professionals are available to assist with result interpretation and clinical decision-making.